Form 4: Molina Healthcare Director Receives Stock Grant

Molina Healthcare, Inc. reports a stock grant to Director Stephen H. Lockhart under the 2025 Equity Incentive Plan.

Summary

• Stephen H. Lockhart, a Director at Molina Healthcare, Inc., received a grant of 237 shares of common stock on July 1, 2026.
• This grant is part of the Issuer's 2025 Equity Incentive Plan and is in connection with his services as a Director.
• The annual equity award for directors is set at $220,000, with one quarter ($55,000) granted on the first day of each quarter.
• The number of shares granted is based on the closing price of the Issuer's common stock on the grant date.
• On July 1, 2026, the closing price was $232.55 per share, resulting in the 237-share grant.
• Following the transaction, Mr. Lockhart beneficially owns 4,384 shares of common stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a routine equity grant to a director as part of established compensation practices, with no significant new financial information or strategic shifts disclosed.

Positives

• Director compensation aligns with a structured equity incentive plan.
• The grant is tied to the company's stock performance, reflecting a performance-based incentive.
• The transaction indicates continued engagement and compensation for a key leadership role.

Future Outlook

The filing does not contain specific forward-looking statements or guidance beyond the described equity grant structure.

Management Comments

• "The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day."
• "Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director."

Industry Context

StockSavvy.ai notes that equity grants to directors are a standard practice in the healthcare industry to align executive and director interests with shareholder value and to attract and retain talent in a competitive market.

Corporate Governance

Stakeholder Impact

• Shareholders: The grant aligns director compensation with stock performance, potentially incentivizing actions that benefit shareholders. The direct ownership by the director increases.
• Employees: The filing does not directly impact employees, but the incentive structure for directors may indirectly influence company strategy.
• Management: Confirms the ongoing compensation structure for directors.

Next Steps

• Continued quarterly grants of stock to directors under the 2025 Equity Incentive Plan.
• Stephen H. Lockhart will continue to hold his position as Director.

Key Dates

Keywords

Molina Healthcare, MOH, Form 4, SEC Filing, Stock Grant, Director Compensation, Equity Incentive Plan, Beneficial Ownership, Insider Trading